Stay updated on PROMO: Pembrolizumab in Osteosarcoma Clinical Trial

Sign up to get notified when there's something new on the PROMO: Pembrolizumab in Osteosarcoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PROMO: Pembrolizumab in Osteosarcoma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The ClinicalTrials.gov page footer now displays site revision v3.8.1 instead of v3.8.0.
    Difference
    0.1%
    Check dated 2026-11-21T13:17:31.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The osteosarcoma pembrolizumab trial record is displayed with its study design, eligibility criteria, outcomes, locations, and record history. It indicates the trial was terminated after inclusion stopped because no more than two patients had clinical benefit.
    Difference
    46%
    Check dated 2026-11-07T12:43:46.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.2 to v3.8.0 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T13:25:55.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    A banner announces NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence.” It does not add information about the clinical trial.
    Difference
    1%
    Check dated 2026-10-24T15:14:23.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    The footer revision marker changed from v3.7.1 to v3.7.2 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-17T15:08:49.000Z thumbnail image
  7. Check
    43 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.0 to v3.7.1, while the study page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T15:14:36.000Z thumbnail image

Stay in the know with updates to PROMO: Pembrolizumab in Osteosarcoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PROMO: Pembrolizumab in Osteosarcoma Clinical Trial page.